Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2024-11-01
|
| Schriftenreihe: | Journal of Pharmaceutical Analysis |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2095177924000984 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|